Moneycontrol PRO

you are here: HomeNewsBusinessIPO3 Point Analysis | Rossari Biotech's stellar listing: What should investors do now?

SHOW NAMES

Trending Topics

X

business

3 Point Analysis | Rossari Biotech's stellar listing: What should investors do now?

The stock opened with a premium of Rs 245, or 58 percent, on the BSE against its issue price of Rs 425 per share, and rose to Rs 710 intraday, i.e. 67.1 percent higher

first published: Jul 23, 2020 09:20 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347